首頁 > 市場調查報告書 > 醫療設備

醫學影像診斷

市場調查報告書

商品編碼

1609671

2024-2032 年日本數位病理學市場報告（按產品、類型、交付模式、應用、最終用戶和地區）

Japan Digital Pathology Market Report by Product, Type, Delivery Model, Application, End User, and Region 2024-2032

出版日期: 2024年12月05日 | 出版商:

IMARC | 英文 119 Pages | 商品交期: 5-7個工作天內

價格

簡介目錄

2023年日本數位病理IMARC Group規模達3,611萬美元。主要參與者對醫療保健技術的廣泛投資主要推動了市場的成長。

數位病理學是一種尖端醫療技術，徹底改變了檢查組織樣本進行疾病診斷的傳統做法。數位病理學不使用傳統的玻片，而是將組織樣本數位化為高解析度影像。然後以電子方式儲存、分析和共享這些數位影像，使病理學家和醫療專業人員能夠遠端協作和診斷。數位病理學具有許多優勢，包括提高診斷癌症等疾病的準確性、速度和效率。它還促進人工智慧和機器學習演算法的整合，有助於實現影像分析某些方面的自動化並提高診斷精度。此外，數位病理學可以創建廣泛的數位檔案，使研究人員能夠存取和研究用於各種目的的大量醫療資料儲存庫，包括醫學研究、教育和醫療保健環境中的品質保證。

日本數位病理市場趨勢：

日本的數位病理市場正在見證該國醫療保健領域的顯著成長和轉型。日本以其技術進步而聞名，正在將數位病理學作為加強疾病診斷和患者護理的強大工具。該技術的採用透過數位化病理切片簡化了組織樣本分析過程，允許病理學家之間進行遠端協作並實現更快、更準確的診斷。隨著人口老化的不斷加劇，對精確、及時的病理服務的需求不斷增加，這使得數位病理成為有效管理醫療保健需求的寶貴資產。此外，將人工智慧和機器學習整合到數位病理學系統中進一步增強了診斷能力。這些創新不僅提高了診斷準確性，還有助於解決該國病理學家短缺帶來的挑戰。隨著日本繼續投資醫療保健技術，數位病理市場預計將持續成長和創新，以滿足醫療保健產業不斷變化的需求。

日本數位病理學市場細分：

產品見解：

掃描儀
軟體
儲存系統
通訊系統

類型見解：

人類病理學
獸醫病理學

交付模式見解：

本地
主辦

應用見解：

培訓和教育
諮詢服務
術中諮詢
常規診斷諮詢服務
其他

最終使用者見解：

製藥和生物技術公司
醫院和參考實驗室
學術及研究機構

競爭格局：

市場研究報告也對競爭格局進行了全面分析。報告涵蓋了市場結構、關鍵參與者定位、最佳制勝策略、競爭儀表板和公司評估象限等競爭分析。此外，也提供了所有主要公司的詳細資料。

本報告回答的關鍵問題：

日本數位病理市場迄今表現如何，未來幾年將如何表現？
COVID-19 對日本數位病理市場有何影響？
日本數位病理市場依產品分類是怎樣的？
日本數位病理市場按類型分類是怎樣的？
日本數位病理市場在交付模式上的分類是怎麼樣的？
日本數位病理市場在應用方面的細分如何？
日本數位病理市場在最終用戶方面的詳細情形如何？
日本數位病理市場價值鏈的各個階段是什麼？
日本數位病理學的關鍵促進因素和挑戰是什麼？
日本數位病理市場的結構如何？
日本數位病理市場的競爭程度如何？

本報告回答的關鍵問題：

日本數位病理市場迄今表現如何，未來幾年將如何表現？
COVID-19 對日本數位病理市場有何影響？
日本數位病理市場依產品分類是怎樣的？
日本數位病理市場按類型分類是怎樣的？
日本數位病理市場在交付模式上的分類是怎麼樣的？
日本數位病理市場在應用方面的細分如何？
日本數位病理市場在最終用戶方面的詳細情形如何？
日本數位病理市場價值鏈的各個階段是什麼？
日本數位病理學的關鍵促進因素和挑戰是什麼？
日本數位病理市場的結構如何？
日本數位病理市場的競爭程度如何？

掃描儀
- 概述
- 歷史與當前市場趨勢（2018-2023）
- 市場預測（2024-2032）
軟體
- 概述
- 歷史與當前市場趨勢（2018-2023）
- 市場預測（2024-2032）
儲存系統
- 概述
- 歷史與當前市場趨勢（2018-2023）
- 市場預測（2024-2032）
通訊系統
- 概述
- 歷史與當前市場趨勢（2018-2023）
- 市場預測（2024-2032）

第 7 章：日本數位病理市場 - 細分：按類型

人類病理學
- 概述
- 歷史與當前市場趨勢（2018-2023）
- 市場預測（2024-2032）
獸醫病理學
- 概述
- 歷史與當前市場趨勢（2018-2023）
- 市場預測（2024-2032）

第 8 章：日本數位病理市場 - 細分：按交付模式

本地
- 概述
- 歷史與當前市場趨勢（2018-2023）
- 市場預測（2024-2032）
主辦
- 概述
- 歷史與當前市場趨勢（2018-2023）
- 市場預測（2024-2032）

第 9 章：日本數位病理市場 - 細分：按應用分類

培訓和教育
- 概述
- 歷史與當前市場趨勢（2018-2023）
- 市場預測（2024-2032）
諮詢服務
- 概述
- 歷史與當前市場趨勢（2018-2023）
- 市場預測（2024-2032）
術中諮詢
- 概述
- 歷史與當前市場趨勢（2018-2023）
- 市場預測（2024-2032）
常規診斷諮詢服務
- 概述
- 歷史與當前市場趨勢（2018-2023）
- 市場預測（2024-2032）
其他
- 歷史與當前市場趨勢（2018-2023）
- 市場預測（2024-2032）

第 10 章：日本數位病理市場 - 細分：按最終用戶分類

製藥和生物技術公司
- 概述
- 歷史與當前市場趨勢（2018-2023）
- 市場預測（2024-2032）
醫院和參考實驗室
- 概述
- 歷史與當前市場趨勢（2018-2023）
- 市場預測（2024-2032）
學術及研究機構
- 概述
- 歷史與當前市場趨勢（2018-2023）
- 市場預測（2024-2032）

第 11 章：日本數位病理市場 - 競爭格局

概述
市場結構
市場參與者定位
最佳制勝策略
競爭儀表板
公司評估象限

第 12 章：關鍵參與者簡介

Company A

Business Overview
Product Portfolio
Business Strategies
SWOT Analysis
Major News and Events

Company B

Business Overview
Product Portfolio
Business Strategies
SWOT Analysis
Major News and Events

Company C

Business Overview
Product Portfolio
Business Strategies
SWOT Analysis
Major News and Events

Company D

Business Overview
Product Portfolio
Business Strategies
SWOT Analysis
Major News and Events

Company E

Business Overview
Product Portfolio
Business Strategies
SWOT Analysis
Major News and Events

第 13 章：日本數位病理市場 - 產業分析

促進因素、限制因素和機會
- 概述
- 促進要素
- 限制
- 機會
波特五力分析
- 概述
- 買家的議價能力
- 供應商的議價能力
- 競爭程度
- 新進入者的威脅
- 替代品的威脅
價值鏈分析

第 14 章：附錄

簡介目錄

Product Code: SR112024A18022

Japan digital pathology market size reached US$ 36.11 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 118.34 Million by 2032, exhibiting a growth rate (CAGR) of 13.50% during 2024-2032. The widespread investments by key players in the healthcare technologies are primarily driving the market growth.

Digital pathology is a cutting-edge medical technology that revolutionizes the traditional practice of examining tissue samples for disease diagnosis. Instead of using conventional glass slides, digital pathology involves the digitization of tissue samples into high-resolution images. These digital images are then stored, analyzed, and shared electronically, enabling pathologists and medical professionals to collaborate and make diagnoses remotely. Digital pathology offers numerous advantages, including improved accuracy, speed, and efficiency in diagnosing diseases such as cancer. It also facilitates the integration of artificial intelligence and machine learning algorithms, which can assist in automating certain aspects of image analysis and enhancing diagnostic precision. Additionally, digital pathology allows for the creation of extensive digital archives, enabling researchers to access and study a vast repository of medical data for various purposes, including medical research, education, and quality assurance in healthcare settings.

Japan Digital Pathology Market Trends:

The digital pathology market in Japan is witnessing significant growth and transformation within the country's healthcare landscape. Japan, known for its technological advancements, is embracing digital pathology as a powerful tool to enhance disease diagnosis and patient care. The adoption of this technology streamlines the process of tissue sample analysis by digitizing pathology slides, allowing for remote collaboration among pathologists and enabling faster and more accurate diagnoses. With a growing aging population, the demand for precise and timely pathology services is increasing, making digital pathology an invaluable asset in managing healthcare needs efficiently. Additionally, the integration of artificial intelligence and machine learning into digital pathology systems is enhancing diagnostic capabilities further. These innovations not only improve diagnostic accuracy but also help address the challenges posed by a shortage of pathologists in the country. As Japan continues to invest in healthcare technologies, the digital pathology market is poised for continued growth and innovation to meet the evolving demands of the healthcare sector.

Japan Digital Pathology Market Segmentation:

Product Insights:

Scanners
Software
Storage Systems
Communication Systems

Type Insights:

Human Pathology
Veterinary Pathology

Delivery Model Insights:

On-premises
Hosted

Application Insights:

Training and Education
Consulting Services
Intraoperative Consultation
Routine Diagnostic Consultation Services
Others

End User Insights:

Pharmaceutical and Biotechnology Companies
Hospitals and Reference Laboratories
Academic and Research Institutes

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

How has the Japan digital pathology market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the Japan digital pathology market?
What is the breakup of the Japan digital pathology market on the basis of product?
What is the breakup of the Japan digital pathology market on the basis of type?
What is the breakup of the Japan digital pathology market on the basis of delivery model?
What is the breakup of the Japan digital pathology market on the basis of application?
What is the breakup of the Japan digital pathology market on the basis of end user?
What are the various stages in the value chain of the Japan digital pathology market?
What are the key driving factors and challenges in the Japan digital pathology?
What is the structure of the Japan digital pathology market and who are the key players?
What is the degree of competition in the Japan digital pathology market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Japan Digital Pathology Market - Introduction

4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence

5 Japan Digital Pathology Market Landscape

5.1 Historical and Current Market Trends (2018-2023)
5.2 Market Forecast (2024-2032)

6 Japan Digital Pathology Market - Breakup by Product

6.1 Scanners
- 6.1.1 Overview
- 6.1.2 Historical and Current Market Trends (2018-2023)
- 6.1.3 Market Forecast (2024-2032)
6.2 Software
- 6.2.1 Overview
- 6.2.2 Historical and Current Market Trends (2018-2023)
- 6.2.3 Market Forecast (2024-2032)
6.3 Storage Systems
- 6.3.1 Overview
- 6.3.2 Historical and Current Market Trends (2018-2023)
- 6.3.3 Market Forecast (2024-2032)
6.4 Communication Systems
- 6.4.1 Overview
- 6.4.2 Historical and Current Market Trends (2018-2023)
- 6.4.3 Market Forecast (2024-2032)

7 Japan Digital Pathology Market - Breakup by Type

7.1 Human Pathology
- 7.1.1 Overview
- 7.1.2 Historical and Current Market Trends (2018-2023)
- 7.1.3 Market Forecast (2024-2032)
7.2 Veterinary Pathology
- 7.2.1 Overview
- 7.2.2 Historical and Current Market Trends (2018-2023)
- 7.2.3 Market Forecast (2024-2032)

8 Japan Digital Pathology Market - Breakup by Delivery Model

8.1 On-premises
- 8.1.1 Overview
- 8.1.2 Historical and Current Market Trends (2018-2023)
- 8.1.3 Market Forecast (2024-2032)
8.2 Hosted
- 8.2.1 Overview
- 8.2.2 Historical and Current Market Trends (2018-2023)
- 8.2.3 Market Forecast (2024-2032)

9 Japan Digital Pathology Market - Breakup by Application

9.1 Training and Education
- 9.1.1 Overview
- 9.1.2 Historical and Current Market Trends (2018-2023)
- 9.1.3 Market Forecast (2024-2032)
9.2 Consulting Services
- 9.2.1 Overview
- 9.2.2 Historical and Current Market Trends (2018-2023)
- 9.2.3 Market Forecast (2024-2032)
9.3 Intraoperative Consultation
- 9.3.1 Overview
- 9.3.2 Historical and Current Market Trends (2018-2023)
- 9.3.3 Market Forecast (2024-2032)
9.4 Routine Diagnostic Consultation Services
- 9.4.1 Overview
- 9.4.2 Historical and Current Market Trends (2018-2023)
- 9.4.3 Market Forecast (2024-2032)
9.5 Others
- 9.5.1 Historical and Current Market Trends (2018-2023)
- 9.5.2 Market Forecast (2024-2032)

10 Japan Digital Pathology Market - Breakup by End User

10.1 Pharmaceutical and Biotechnology Companies
- 10.1.1 Overview
- 10.1.2 Historical and Current Market Trends (2018-2023)
- 10.1.3 Market Forecast (2024-2032)
10.2 Hospitals and Reference Laboratories
- 10.2.1 Overview
- 10.2.2 Historical and Current Market Trends (2018-2023)
- 10.2.3 Market Forecast (2024-2032)
10.3 Academic and Research Institutes
- 10.3.1 Overview
- 10.3.2 Historical and Current Market Trends (2018-2023)
- 10.3.3 Market Forecast (2024-2032)

11 Japan Digital Pathology Market - Competitive Landscape

11.1 Overview
11.2 Market Structure
11.3 Market Player Positioning
11.4 Top Winning Strategies
11.5 Competitive Dashboard
11.6 Company Evaluation Quadrant

12 Profiles of Key Players

12.1 Company A
- 12.1.1 Business Overview
- 12.1.2 Product Portfolio
- 12.1.3 Business Strategies
- 12.1.4 SWOT Analysis
- 12.1.5 Major News and Events
12.2 Company B
- 12.2.1 Business Overview
- 12.2.2 Product Portfolio
- 12.2.3 Business Strategies
- 12.2.4 SWOT Analysis
- 12.2.5 Major News and Events
12.3 Company C
- 12.3.1 Business Overview
- 12.3.2 Product Portfolio
- 12.3.3 Business Strategies
- 12.3.4 SWOT Analysis
- 12.3.5 Major News and Events
12.4 Company D
- 12.4.1 Business Overview
- 12.4.2 Product Portfolio
- 12.4.3 Business Strategies
- 12.4.4 SWOT Analysis
- 12.4.5 Major News and Events
12.5 Company E
- 12.5.1 Business Overview
- 12.5.2 Product Portfolio
- 12.5.3 Business Strategies
- 12.5.4 SWOT Analysis
- 12.5.5 Major News and Events

13 Japan Digital Pathology Market - Industry Analysis

13.1 Drivers, Restraints, and Opportunities
- 13.1.1 Overview
- 13.1.2 Drivers
- 13.1.3 Restraints
- 13.1.4 Opportunities
13.2 Porters Five Forces Analysis
- 13.2.1 Overview
- 13.2.2 Bargaining Power of Buyers
- 13.2.3 Bargaining Power of Suppliers
- 13.2.4 Degree of Competition
- 13.2.5 Threat of New Entrants
- 13.2.6 Threat of Substitutes
13.3 Value Chain Analysis